<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-11020-2015194 - 2S3UI</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Strategic funding to coordinate and leverage current initiatives that address intellectual property (IP) barriers that impede access to medicines in middle-income countries (MICs).</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">Bringing together the IP work, bridging the programs from different donors and most importantly increasing the impact of this work for people living with HIV</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="EN">In middle-income countries there is an increased focus on addressing IP challenges as a major barrier to access to essential medicines. At global level, a set of recommendations emanated from the Global Commission on HIV and the Law, with a clear call on the UN Secretary General to facilitate the development of a new framework for IP. In short, many stakeholders now agree that IP is the next big human rights challenge on the horizon to address HIV and related co-infections. While there are now a few donor agencies (OSF, Aids Fonds and UNITAID), funding greater civil society engagement in this area, it is also clear that civil society is fractured in terms of the best possible strategies.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">There is a constant and growing pool of lawyers, IP specialists and community activists who work on Intellectual Property issues, but they do so under difficult circumstances and with very limited resources. In addition, in many parts of the world, civil society is lacking the experience and technical knowledge needed to meaningfully engage at national and global level on questions of IP laws, TRIPS flexibilities and trade negotiations. Additionally, the existing national/regional advocacy initiatives led by civil society are not linked to each other and lack coordination to feed a global campaign aiming to advance the IP and access agenda at higher political level. With this funding, ITPC can play a coordinating role of the different efforts of civil society; bringing together the IP work, bridging the programs from different donors and most importantly increasing the impact of this work for people living with HIV. The project will focus on the following areas of work:
- To build capacity on IP within civil society, especially in middle-income countries, in order to develop national strategies and engagement plans with governments, regional organizations and the generic and originator pharmaceutical industry.
- To build greater solidarity among civil society organizations across the globe to pursue a common agenda and to facilitate inter-country and cross-organizational learning especially among countries that have engaged out of need, in these debates for some time and those who are just entering this stream of work.
- To coordinate the many different actions at country level and in different regions and to ensure that lessons learned from these actions are understood to be part of a global advocacy campaign which addresses global policy makers, normative guidance agencies and donor agencies.</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <participating-org ref="BW-CO2-0151011" role="4" type="21">
   <narrative xml:lang="EN">ITPC Global</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2015-12-31" type="1"></activity-date>
  <activity-date iso-date="2018-08-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <recipient-country code="AR" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="BR" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="BW" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="CO" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="EG" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="GE" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="ID" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="IN" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="KG" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="KZ" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="MA" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="MD" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="MM" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="MU" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="MX" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="MY" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="TN" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="VN" percentage="5.2631578947368425"></recipient-country>
  <recipient-country code="ZW" percentage="5.2631578947368425"></recipient-country>
  <location>
   <name>
    <narrative xml:lang="EN">Global IP coordinator based in Marrakech, Morocco</narrative>
   </name>
  </location>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Strategic funding to coordinate and leverage current initiatives that address intellectual property (IP) barriers that impede access to medicines in middle-income countries (MICs). STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2015-12-31"></period-start>
   <period-end iso-date="2018-08-31"></period-end>
   <value currency="EUR" value-date="2015-12-31">120000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">32000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2015194</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">32000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2015194</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-06-26"></transaction-date>
   <value currency="EUR" value-date="2016-06-26">32000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-06-27"></transaction-date>
   <value currency="EUR" value-date="2016-06-27">32000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-12-27"></transaction-date>
   <value currency="EUR" value-date="2016-12-27">32000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-12-27"></transaction-date>
   <value currency="EUR" value-date="2016-12-27">32000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-07-27"></transaction-date>
   <value currency="EUR" value-date="2017-07-27">21000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-07-28"></transaction-date>
   <value currency="EUR" value-date="2017-07-28">21000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-25"></transaction-date>
   <value currency="EUR" value-date="2019-01-25">3000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-25"></transaction-date>
   <value currency="EUR" value-date="2019-01-25">3000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="BW-CO2-0151011">
    <narrative xml:lang="EN">ITPC Global</narrative>
   </receiver-org>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">B. Coordinate advocacy efforts in key events</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Coordinated advocacy efforts at international events</narrative>
   </description>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">B1. Number of coordinated activities</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="5"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="1"></target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">A. Increase communication and information exchange among CSOs</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Development make Medicines Affordable website</narrative>
   </description>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A2. Number of followers of MMA Facebook page</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="200"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A3. Number of posts shared in MMA mailing list</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="21"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A1. Number of visits to MMA website</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="2929"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">A4. Number of teleconferences</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="9"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">C. Document CS interventions and research around intellectual property and access to medicines</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Production of a CS friendly tool on IP and access to medicines</narrative>
   </description>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C2. Number of publications</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="0"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C1. Number of Tools on IP and access to medicines</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="1"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
   <indicator measure="1">
    <title>
     <narrative xml:lang="EN">C3. Number of blogs/stories published</narrative>
    </title>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2016-12-31"></period-end>
     <actual value="16"></actual>
    </period>
    <period>
     <period-start iso-date="2016-01-01"></period-start>
     <period-end iso-date="2017-12-31"></period-end>
     <target value="0"></target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
